Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page
- Check4 days agoChange DetectedThe page now indicates that recruitment has closed and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a standardized header label for the Intervention/Treatment section.SummaryDifference0.2%

- Check11 days agoChange DetectedRevision tag updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer version of the document.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision stamp updated from v3.5.3 to v3.5.4, signaling a new version of the page's documentation. The change is a minor backend update rather than a substantive alteration to study details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe Sweden location entry in the study's locations list has been updated from Malmo to Malmö, correcting the city spelling in Skåne County. This preserves an accurate and searchable location for participants and records.SummaryDifference0.0%

- Check53 days agoChange DetectedA new related publication (on CD8+ T cells in ankylosing spondylitis) is added to the study’s publications list. The site’s displayed release/version label is updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.